Canada Markets closed

Nuvo Pharmaceuticals Inc. (MRVFF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.97950.0000 (0.00%)
At close: 03:42PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) N/A
Enterprise Value N/A
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)N/A
Price/Book (mrq)N/A
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA N/A

Trading Information

Stock Price History

Beta (5Y Monthly) 0.81
52-Week Change 3N/A
S&P500 52-Week Change 3N/A
52 Week High 31.1764
52 Week Low 30.4174
50-Day Moving Average 30.9758
200-Day Moving Average 30.6636

Share Statistics

Avg Vol (3 month) 37.92k
Avg Vol (10 day) 33.63k
Shares Outstanding 511.39M
Implied Shares Outstanding 6N/A
Float 88.93M
% Held by Insiders 14.71%
% Held by Institutions 115.35%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21354:1000
Last Split Date 3Mar 06, 2016

Financial Highlights

Currency in CAD.

Fiscal Year

Fiscal Year Ends Dec 30, 2021
Most Recent Quarter (mrq)Sept 29, 2022


Profit Margin 20.95%
Operating Margin (ttm)16.94%

Management Effectiveness

Return on Assets (ttm)5.85%
Return on Equity (ttm)1,180.47%

Income Statement

Revenue (ttm)72.42M
Revenue Per Share (ttm)6.36
Quarterly Revenue Growth (yoy)6.70%
Gross Profit (ttm)44.46M
Net Income Avi to Common (ttm)15.17M
Diluted EPS (ttm)-1.6820
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)31.26M
Total Cash Per Share (mrq)2.74
Total Debt (mrq)98.92M
Total Debt/Equity (mrq)1,165.85
Current Ratio (mrq)2.11
Book Value Per Share (mrq)-0.52

Cash Flow Statement

Operating Cash Flow (ttm)15.54M
Levered Free Cash Flow (ttm)10.33M